Oct 30 , 2018

Judith Van Walsum Joins ZH Healthcare Board

Roche Diabetes Care’s Global Head of Finance, Judith van Walsum, joins the Board of ZH Healthcare, the creators of blueEHR: HITaaS™


ZH Healthcare, Inc., pioneers in Health IT as a Service with its product blueEHR-HITaaS,  announced today that Judith Van Walsum, Global Head of Finance, Compliance & IT at Roche Diabetes Care, has joined its Board of Directors.

Shameem C. Hameed, CEO of ZH Healthcare said, “blueEHR has transitioned to the growth phase over the last year with additions of several marquee clients who operate across the globe, with the latest being Pan American Life Insurance Group. As we enter this breakout phase in the life of the company, adding additional financial talent to the Board is key to guiding the company. We are fortunate to have Judith join our team.”

“I am honored to join the Board of ZH Healthcare and look forward to supporting the company in its pursuit of empowering healthcare organizations building innovative eHealth applications to deliver better care for patients, through blueEHR” states Dr. Van Walsum

Judith is a Roche veteran who has served with various segments of the company over the last 15 years. Before joining Roche, she also served with KPMG Consulting GmbH and BearingPoint GmbH. “Judith is a highly regarded finance professional, and I am pleased to have the opportunity to work with her again as we embark on our next phase of growth,” said Board Member Mark B. Hassenplug. Dr. van Walsum is based in Basel, Switzerland.

About ZH Healthcare, Inc.

ZH Healthcare  is a healthcare technology innovator that is revolutionizing health IT with blueEHR® – Health IT as a Service (HITaaS)®, a cloud-based healthcare specific software development and infrastructure environment that empowers users to build and deploy eHealth solutions quick and efficient. blueEHR, an advanced EHR system borne out of HITaaS is used by thousands of healthcare providers, staff, health systems, startups, and IT companies in 100+ countries.

Share this